This EUPATI Mini-course starter kit is designed for patient involvement in protocol design.
EUPATI Mini-course starter kits have been derived from content found in the EUPATI toolbox and EUPATI Patient Expert Training Course. The starter kits are thought to address roles that patients play in medicines development for example those shown in the figure below.
The starter kits provide you with links to relevant background reading in the toolbox and associated PowerPoint slide decks and media in order to prepare a single or multi-day training on the subject. Each of the starter kits contains a selection of PPT slides which you may use to educate patients/advocates about the “basics” in that area, e.g. in a two-hour to one-day seminar.
The starter kits are based on existing content from the EUPATI Toolbox, plus additional links to add-on Toolbox material. None of the “starter kits” are “ready-made course” modules – they are a ready-to-reuse resource for an experienced trainer to prepare and execute a course. You will need to edit them and put them into context.
Before you begin please download and review the ‘Manual for Trainers’.
- Presentation: Manual for Trainers
Size: 722,143 bytes, Format: .pptx
A manual for trainers describing how to use the EUPATI mini-course starter kits to create trainings on patient involvement.
This starter kit provides background reading, slides, a video, and quizzes to create training for patients who intend to become involved in protocol design.
Early clinical development (coming soon)
- Presentation: The basic principles of medicine discovery and development
Size: 918,164 bytes, Format: .pptx
The basic principles of medicine discovery and development. It takes over 12 years and over €1 billion to do all the research and development necessary before a new medicine is available for patients to use. This presentation details the process from discovery to release of a new medicine onto the market and beyond.
- Presentation: Clinical Trial Designs
Size: 1,179,726 bytes, Format: .pptx
A presentation covering the various types of clinical trial design. Details are given about blinding, control, comparisons, and randomisation.
- Presentation: Evidence-based Medicine
Size: 454,790 bytes, Format: .pptx
A presentation describing evidence based medicine, which can be adapted for own use.
- Presentation: The Role of Statistics in Clinical Trials
Size: 354,126 bytes, Format: .pptx
A presentation describing the role of statistics in clinical trials, which can be adapted for own use.
- Presentation: Statistics in Clinical Trials: Key Concepts
Size: 381,778 bytes, Format: .pptx
A presentation describing the key concepts of statistics in clinical trials, which can be adapted for own use.
- Presentation: Blinding in Clinical Trials
Size: 201,888 bytes, Format: .pptx
This presentation provides more information about the concept of blinding in clinical trials.
- Presentation: Options for Data Collection and Patient-reported Outcomes (PROs)
Size: 611,418 bytes, Format: .pptx
A presentation covering the various types of data collection in clinical trials.
- Presentation: Ethical and Practical Challenges of Organising Clinical Trials in Small Populations.
Size: 495,286 bytes, Format: .pptx
A presentation detailing the ethical and practical challenges of organising clinical trials in small populations.
- Presentation: Paediatric Medicine: The Paediatric Investigation Plan
Size: 479,909 bytes, Format: .pptx
A presentation describing the Paediatric Plan, which can be adapted for own use.
- Presentation: Patient-Reported Outcomes (PROs) Assessment
Size: 408,285 bytes, Format: .pptx
A presentation describing the Patient-Reported Outcomes (PROs) Assessment process, which can be adapted for own use.
- Presentation: Biomarkers
Size: 393,107 bytes, Format: .pptx
A presentation describing biomarkers, which can be adapted for own use.
Quizzes will be provided for each presentation in the future on:
- Making a medicine. Step 1-10
- Clinical Trial Designs
- Evidence-based medicine
- Role of statistics in clinical trials
- The concept of blinding in clinical trials
- Data collection in clinical trials
- Clinical trials in small populations
- Paediatric medicine: Paediatric Investigation Plan
- Patient reported outcomes (PROs) assessment
- Basics of Early Clinical Development
- Phase I Trials
- Phase II Trials
- Types of Study in Early Clinical Development
Explore the history of clinical trials stemming back to 1747 and learn more about how they work today in this short video from the ECRAN project.
Remember that all educational content provided by EUPATI is released under a Creative Commons License, which also applies to all derivatives of it! Therefore
- you must state the license in your course material.
- you must also release your course material under Creative Commons when using EUPATI material.
Example of how to reference material if you have changed something:
“My clinical trials guide” is a derivative of “Phases of Clinical Development” by EUPATI used under CC BY-NC-SA 4.0. “My clinical trials guide” is licensed under CC BY-NC-SA 4.0 by Matthew.
Use of the EUPATI logo
The EUPATI logo is protected by trademark and owned by the European Patients Forum.
Except for the limited purpose of indicating that work is created or licensed by EUPATI (European Patients Academy for Therapeutic Innovation), or collaboration with EUPATI, the European Patients Forum (EPF) does not authorise the use, by any party, of the trademark "EUPATI" or any related trademark or logo of EUPATI without the prior written consent of EPF. Any permitted use will be in compliance with EUPATI's then-current trademark usage guidelines, as may be published on its website or otherwise made available upon request from time to time.